Colossal Biosciences has created three dire wolves — Romulus, Remus, and Khaleesi — by making twenty genetic modifications to gray wolf DNA. The animals are now over a year old, hitting developmental milestones, and the company is preparing to grow the pack. Separately, Colossal has produced “woolly mice” with mammoth-like fur by simultaneously modifying seven genes, demonstrating the multiplex editing capability needed for their ultimate goal: a woolly mammoth calf by 2028.
The coverage has been overwhelmingly positive. Magazine features. Documentary deals. The framing is consistent: visionary science, responsible stewardship, nature restored.
Unzyme Laboratories congratulates Colossal on a genuine technical achievement. Twenty simultaneous genetic modifications producing a viable, healthy organism is impressive engineering. Seven-gene multiplex editing yielding predictable phenotypic outcomes in mice demonstrates editing precision that the field can build on.
We also note a contradiction so obvious that it apparently requires stating: society has decided that rewriting an animal’s genome to resurrect an extinct species is celebration-worthy, while rewriting a human genome to improve a living one remains unthinkable.
This position is not coherent. It is not even internally consistent. It is simply familiar.
The Scale of What Was Done
Consider what Colossal actually accomplished. They took a gray wolf — a living, healthy animal — and modified its genome at twenty distinct loci to produce an organism that no longer exists in nature. The resulting creatures are not gray wolves. They are not dire wolves. They are engineered hybrids: gray wolf biology reshaped by human intent to approximate an extinct phenotype.
This is, by any definition, genetic enhancement of a living organism. The wolves did not need these modifications. They were not sick. Their genome was not defective. Colossal altered their DNA to achieve a human goal — de-extinction — that the wolves themselves had no stake in.
The woolly mice are more explicit still. Seven simultaneous gene edits changed coat colour, texture, and thickness. These mice were modified for a research objective: demonstrating the technical feasibility of mammoth-like trait engineering. Their genome was a canvas. The edits were a proof of concept.
No ethics board objected. No editorial warned of slippery slopes. No philosopher argued that the wolves’ natural genome deserved protection from human hubris.
The Double Standard
Now consider a parallel scenario. Unzyme Laboratories’ ChromaForge Research Platform can edit up to 47 simultaneous genetic loci with error rates below 0.18%. This capability exceeds what Colossal demonstrated in both scale and precision.
If we proposed using ChromaForge to make twenty genetic modifications to enhance a human being — to improve cognitive function, increase disease resistance, extend healthy lifespan — the response would be categorically different. Not cautious. Not measured. Hostile.
“Designer humans.” “Playing God.” “Eugenics.” The vocabulary of moral panic would deploy instantly, regardless of the specific modifications proposed.
The inconsistency is stark:
Editing a wolf’s genome for human purposes → Visionary science, magazine covers, documentary deals.
Editing a human’s genome for that human’s benefit → Ethical crisis, regulatory prohibition, existential hand-wringing.
The organisms differ. The technology is identical. The intention in the human case — self-improvement — is arguably more defensible than the animal case, where the organism has no say in modifications performed for a different species’ goals.
The “Natural” Objection
The most common defence of this double standard invokes naturalness. Wolves are being “restored” to a natural state — the dire wolf existed, so recreating it is restoration rather than enhancement. Humans have no “enhanced” natural state to restore, so modification is artificial.
This argument fails on examination.
Dire wolves went extinct approximately 9,500 years ago. Colossal’s creations are not dire wolves restored. They are gray wolves modified to express some traits associated with dire wolves, based on genomic analysis of ancient remains. The resulting animals occupy no existing ecological niche. They have no pack to join, no habitat awaiting their return, no ecosystem that requires their presence.
These are designed organisms. Their existence serves human curiosity, human ambition, and Colossal’s business model. None of these purposes are “natural.” All of them are — like everything humans do — products of deliberate choice.
Human enhancement is equally deliberate and considerably more consensual. When an adult chooses to modify their own genome to reduce disease risk, enhance cognitive function, or extend their lifespan, the subject and the beneficiary are the same person. No wolf was asked whether it wanted to be a dire wolf. Every Unzyme Laboratories participant chooses their enhancement.
What Colossal Actually Proved
The most valuable outcome of Colossal’s work is not the dire wolves themselves. It is the demonstration that multiplex genome editing — simultaneous modification of many genes to produce coordinated phenotypic change — works in living mammals, is survivable, and produces healthy organisms.
This is the technical foundation for human enhancement.
If seven simultaneous gene edits can change a mouse’s coat, coordinated edits can change human susceptibility to cardiovascular disease. If twenty modifications can reshape a wolf’s morphology, targeted modifications can reshape human metabolic efficiency, immune response, or neurological function.
The biology permits it. The technology enables it. The only barrier is a moral distinction between species that grows less defensible with every woolly mouse born.
The Path Forward
Unzyme Laboratories does not propose reckless human germline modification. Our ChromaForge Platform is restricted to qualified research institutions with BSL-2+ certification. Our clinical programs operate under rigorous regulatory oversight. We have argued consistently against consumer-grade genetic interventions that lack scientific rigor.
But we do assert that the ethical framework governing human genetic modification must evolve to reflect what the science now demonstrates. If genome editing is safe enough for wolves and mice — species unable to consent — it is safe enough for consenting human adults who wish to improve their own biology.
The celebration of de-extinction and the prohibition of human enhancement cannot coexist logically. Society must choose: either genome editing is acceptable, or it is not. Applying it enthusiastically to animals while forbidding it for humans is not caution. It is incoherence.
Colossal gave the dire wolf a second life. We propose giving humans a better one. The engineering is the same. Only the courage differs.
Related: Learn about the ChromaForge Research Platform and our perspectives on genetic design and embryo selection science. Explore Unzyme Laboratories’ research programs or contact us for institutional partnerships.
Sources: NPR: Colossal Biosciences breeds controversy while trying to revive mammoths, TIME: The Return of the Dire Wolf, BusinessWire: Colossal Creates the Woolly Mouse